Lazard Asset Management’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$16.6M Sell
2025
Q1
$21.1M Buy
2024
Q4
$39.8M Buy
2023
Q3
Sell
2023
Q2
$461K Buy
2023
Q1
Sell
2022
Q4
$371K Buy